Zeneca to sue US drug monitor
Tuesday 09 February 1999
The British company took the highly unusual step of suing the US Food and Drug Administration over its decision to allow Gensia Sicor, a small American firm, to produce a cheaper version of its anaesthetic Diprivan.
In a lawsuit filed in the US state of Maryland, Zeneca alleged that the FDA breached an exclusivity agreement and demanded a withdrawal of Gensia's licence.
The little-known US company last month won approval to produce a medicine which uses Diprivan's key ingredient in combination with other substances not contained in the Zeneca product.
The Gensia drug is to be launched later this year and is expected to cost less than Diprivan, an injectable anaesthetic sold to hospitals.
Industry experts believe that it could become a powerful competitor to Diprivan, which last year had sales of $300m in the US and $600m worldwide.
However, the UK group, which is completing its multibillion pound merger with Sweden's Astra, is claiming that the Gensia product breaches a previous agreement with the FDA.
According to Zeneca, the deal gives it exclusive rights over the sale of Diprivan and similar products until June of this year.
The British company is also alleging that Gensia's formulation of the drug could be harmful for patients.
Gensia said it had applied to intervene in the lawsuit between Zeneca and the FDA and added that it would "vigorously protect" its interests.
Missing Malaysia Airlines Flight MH370: Acclaim for retired Australian defence chief Angus Houston who is leading the search for the airliner
South Korea ferry: Four dead and almost 300 missing as mass rescue gets underway
Malaysia Airlines MH370 co-pilot's phone 'was on and made contact with network tower' 30 minutes after plane turned around
Oscar Pistorius trial: Reeva Steenkamp told athlete she 'loved him' for first time in Valentine's Day card
Lunar eclipse 2014: Images of the spectacular 'blood moon'
David Cameron: 'Jesus invented the Big Society – I'm just continuing God's work'
The food poverty scandal that shames Britain: Nearly 1m people rely on handouts to eat – and benefit reforms may be to blame
US Navy christens huge $3 billion destroyer ship USS Zumwalt that appears as a fishing boat on enemy radar
Nigel Farage fatigue? Half of voters ‘immune’ to Ukip’s appeal
Scottish independence: It is the English who should be on their knees, begging the Scots to vote ‘No’
Nigel Farage on Have I Got News For You: Ukip leader ridiculed over expenses and party 'fruitcakes'
- 1 Refugee facing deportation from Sweden saved by fellow passengers refusing to let plane leave
- 2 Naked yoga: the bare truth - it's already big in the US, and has now landed here
- 3 Man on a leash in Farringdon, London: Mystery of 'walkies' solved
- 4 24 people applied for the 'world's toughest job', here are their interviews
- 5 Drugs giant GlaxoSmithKline bribed doctors to boost sales, says whistleblower
iJobs Money & Business
£40000 - £50000 per annum + BONUS + BENEFITS: Harrington Starr: A leading, Cit...
£35000 - £50000 per annum + Bonus + Benefits: Pro-Recruitment Group: You must ...
£45000 - £60000 per annum + BONUS + BENEFITS: Harrington Starr: Corporate Acti...
£350 - £400 per day: Harrington Starr: An opportunity has arisen at a FCA regu...